Lannett's abbreviated new drug application to market its drug for symptomatic treatment of allergic reactions, a generic version of Lyne Laboratories' cyproheptadine hydrochloride syrup, was approved by the FDA.
Lannett's ANDA for allergic reaction generic drug gets FDA nod
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.